Comparison of the cardiovascular effects of the novel 5-HT(1B/1D) receptor agonist, SB 209509 (VML251), and sumatriptan in dogs

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 1, 1997, Pages 136-141

  Parsons, Andrew A ^a   Parker, Stephen G ^a   Raval, Pravin ^a   Campbell, Colin A ^a   Lewis, V Ann ^a   Griffiths, Robin ^a   Hunter, A Jackie ^a   Hamilton, Thomas C ^a   King, Frank D ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

5 HT((1B)5 HT(1D)Dog; Carotid vascular resistance; Coronary vascular resistance; SB 209509; Sumatriptan

Indexed keywords

3 METHYLAMINO 6 CARBOXAMIDO 1,2,3,4 TETRAHYDROCARBAZOLE CAMPHOR SULFONATE; FROVATRIPTAN; SEROTONIN AGONIST; SUMATRIPTAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RESPONSE; CAROTID ARTERY; CONCENTRATION RESPONSE; CORONARY ARTERY BLOOD FLOW; DOG; DOSE RESPONSE; DRUG ABSORPTION; DRUG POTENCY; FEMALE; INTRADUODENAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; VASCULAR RESISTANCE; VASOCONSTRICTION;

ANIMALS; BIOLOGICAL AVAILABILITY; BLOOD PRESSURE; CARBAZOLES; CARDIOVASCULAR SYSTEM; CAROTID ARTERIES; CORONARY CIRCULATION; CORONARY VESSELS; DOGS; DUODENUM; FEMALE; HEART RATE; INFUSIONS, INTRAVENOUS; MALE; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT1D; RECEPTORS, SEROTONIN; REGIONAL BLOOD FLOW; SEROTONIN AGONISTS; SUMATRIPTAN; TRYPTAMINES; VASCULAR RESISTANCE;

EID: 0030712934     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199707000-00020     Document Type: Article

References (24)

1. Johnston BM, Saxena PR. The effect of ergotamine on tissue blood flow and the arteriovenous shunting of radioactive microspheres in the head. Br J Pharmacol 1978;63:541-9.
2. Spierings ELH, Saxena PR. Antimigraine drugs and cranial arteriovenous shunting in the cat. Neurology 1980;30:676-701.
3. Perren MJ, Feniuk W, Humphrey PPA. The selective closure of feline carotid arteriovenous anastomoses (AVAs) by GR 43175. Cephalalgia 1989;9(suppl 9):41-6.
4. Feniuk W, Humphrey PPA, Perren MJ. The selective carotid arterial vasoconstrictior action of GR 43175 in anaesthetized dogs. Br J Pharmacol 1989;96:83-90.
5. 1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan. Br J Pharmacol 1991;102:323-30.
6. Saxena PR. The pathogenesis and pharmacology of migraine. Rev Contemp Pharmacother 1994;5:259-69.
7. Rowbotham GF, Little E. New concepts on the aetiology and vascularization of meningiomata: the mechanism of migraine, the chemical process of cerebrospinal fluids, and the formation of collections of blood or fluid in the subdural space. Br J Surg 1965;52:21-4.
8. Lambert GA, Bogduk N, Goadsby PJ, Duckworth JW, Lance JW. Decreased carotid arterial resistance in cats in response to trigeminal stimulation. J Neurosurg 1984;61:307-15.
9. Spokes R, Middlefell VC. Simultaneous measurement of plasma protein extravasation and CdVR in the rat. Eur J Pharmacol 1995;281:75-9.
10. 1D receptor subtypes. Trends Pharmacol Sci 1996;17:103-5.
11. 1-like receptor in dog isolated saphenous vein. Br J Pharmacol 1988;94:1123-32.
12. 1-like receptors mediate 5-HT induced contraction of human isolated basilar artery. Br J Pharmacol 1989;96:434-40.
13. Kaumann AJ, Parsons AA, Brown AM. Human arterial constrictor 5-HT receptors. Cardiovasc Res 1993;27:2094-103.
14. 2 receptors in serotonin-induced contractions of human isolated coronary arteries. Circulation 1994;90:1141-53.
15. 2 receptor activation. Eur J Pharmacol 1989;161:91-4.
16. Bax WA, Renzenbrink GJ, van Heuven-Nolsen D, Thijssen EJM, Bos E, Saxena PR. 5-HT receptors mediating contractions of the isolated human coronary artery. Eur J Pharmacol 1993;239: 203-10.
17. 1D receptors. Br J Pharmacol 1996;119:110P.
18. Raval P, Tilford NS, Smith SJ, et al. A comparison of the agonist profile of SB 209509 (VML 251) and sumatriptan in human isolated basilar and coronary arteries. Br J Pharmacol 1996;119:111P.
19. Cushing DJ, Cohen ML. Comparison of the serotonin receptors that mediate smooth muscle contraction in canine and porcine coronary artery. J Pharmacol Exp Ther 1992;61:856-62.
20. 1-like receptors. Naunyn-Schmiedbergs Arch Pharmacol 1992;346: 592-6.
21. 1D receptor. Life Sci 1994;54:1671-80.
22. 1-like receptors mediating vasoconstriction and vasodilatation: their characterization and distribution in the intact canine cardiovascular system. Br J Pharmacol 1995;114:961-8.
23. 7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery. J Pharmacol Exp Ther 1996;277:1560-6.
24. 7 receptor subtype. Br J Pharmacol 1996;118:1421-8.